The role of gene-environment interaction in the aetiology of human cancer: Examples from cancers of the large bowel, lung and breast

Journal of Internal Medicine

Volumn 249, Issue 6, 2001, Pages 477-493

  Mucci, L A ^a   Wedren, S ^b   Tamimi, R M ^a   Trichopoulos, D ^a,b   Adami, H O ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Cancer; Gene environment; Interactions; Molecular epidemiology; Polymorphisms

Indexed keywords

ACYLTRANSFERASE; CARCINOGEN; CYTOCHROME P450; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; GLUTATHIONE TRANSFERASE;

BREAST CANCER; CANCER; CANCER GENETICS; CANCER RISK; CARCINOGENESIS; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; GENE; GENETIC POLYMORPHISM; HUMAN; LARGE INTESTINE CANCER; LUNG CANCER; MOLECULAR BIOLOGY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

BREAST NEOPLASMS; CARCINOGENS; COLORECTAL NEOPLASMS; ENVIRONMENT; EPIDEMIOLOGY, MOLECULAR; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG NEOPLASMS; MALE; POLYMORPHISM, GENETIC; RISK FACTORS;

EID: 0034847397     PISSN: 09546820     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2796.2001.00839.x     Document Type: Review

References (133)

1. The causes of cancer: Quantitative estimates of avoidable risks of cancer in the United States today
2. What causes cancer?
3. Cancer incidence patterns 1972-91 among migrants from the Soviet Union to Israel
4. The incidence of gastric carcinoma in Asian migrants to the United States and their descendants
5. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland
6. Cancer-nature, nurture, or both
7. Gene-environment interactions in human disease
8. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence
9. Population-based study of risk of breast cancer in carriers of BRCA2 mutation
10. Concepts of Interaction
11. Genetic epidemiology
12. -acetyltransferase
13. Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogens
14. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyl transferases
15. Polyadenylation polymorphism in the acetyltransferase 1 gene (NAT1) increases risk of colorectal cancer
16. Human acetyltransferase polymorphisms
17. Genetic polymorphisms of human N-acetyltransferase, cyto-chrome P450, glutathione S-transferase, and epoxide hydrolase enzymes: Relevance to xenobiotic metabolism and toxicity
18. Molecular genetics of human polymorphic N-acetyltransferase: Enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes
19. Polymorphic NAT's and cancer predisposition, Chapter 20
20. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
21. Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes
22. The human hepatic cytochromes P450 involved in drug metabolism
23. CYP1A1, Chapter 15
24. Abnormal oxidative metabolism of estradiol in women with breast cancer
25. A novel CYP1A1 gene polymorphism in African-Americans
26. Functional role of estrogen metabolism in target cells
27. Activation of chemically diverse procarcinogens by human cytochrome P-450 1B1
28. Association of cytochrome P450 1B1 (CYP1B1) with steroid receptor status in breast cancer
29. Cytochrome P450 1B1 (CYP1B1) pharmacogenetics: Association of polymorphisms with functional differences in estrogen hydroxylation activity
30. Cytochrome P450c17α is associated with serum estrogen and progesterone concentrations
31. A polymorphism in the CYP17 gene increases the risk of breast cancer
32. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT. A multigenic study on cancer susceptibility
33. No association of the 5′ promoter region polymorphism of CYP17 with breast cancer risk in Japan
34. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years
35. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer
36. A tetranucleotide repeat polymorphism in CYP19 and breast cancer risk
37. Genetic variants of CYP19 (aromatase) and breast cancer risk
38. Glutathione S-transferases, structure regulation and therapeutic implications
39. A glutathione S-transferase in human leukocytes as a marker for the susceptibility to lung cancer
40. Immunohistochemical localization of glutathione S-transferases in human lung
41. The glutathione S-transferases: Influence of polymorphism on cancer susceptibility, Chapter 19
42. Glutathione and Glutathione S-transferases in human squamous cell carcinomas of the larynx and GSTM1 dependent risk
43. Hereditary differences in the expression of the human glutathione transferase active on trans-stilbene oxide are due to a gene deletion
44. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of genetic polymorphism
45. Polycyclic aromatic hydrocarbon-DNA adducts in human lung and cancer susceptibility genes
46. Increased cytogenetic damage in smokers deficient in glutathione S-transferase isozyme mu
47. Bimodal distribution of sensitivity to SCE induction by diepoxybutane in human lymphocytes. I. Correlation with chromosomal aberrations
48. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes
49. Laboratory methods for the determination of genetic polymorphisms in humans, Chapter 13
50. Design and analysis issues in case-control studies addressing genetic susceptibility, Chapter 12
51. How to evaluate interaction between causes: A review of practices in cardiovascular epidemiology
52. Statistical analysis of molecular epidemiology studies employing case-series
53. Sample size requirement in case-only designs to detect gene-environment interaction
54. Diet and colorectal cancer: A case-control study in Greece
55. A case control study of diet and colorectal cancer in northern Italy
56. Relation of meat, fat and fiber intake to the risk of colon cancer in a prospective study among women
57. Diet and colon cancer in Los Angeles County, California
58. Intake of fat, meat, and fiber in relation to risk of colon cancer in men
59. Ulcerative colitis and colorectal cancer. A population-based study
60. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
61. Acetylation polymorphism and prevalence of colorectal adenomas
62. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England
63. A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer
64. Western diet, family history of colorectal cancer, NAT2, GSTM-1 and risk of colon cancer
65. Meat consumption, genetic susceptibility, and colon cancer risk: A United States multicenter case-control study
66. Inherited polymorphism in the N-acetyltransferase 1 (NAT1) and 2 (NAT2) genes and susceptibility to gastric and colorectal adenocarcinoma
67. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer
68. Glutathione S transferase MI (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma
69. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility to colon cancer and age of onset
70. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: Studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers
71. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk. A prospective study
72. Cigarette smoking, CYP1A1 MspI and GSTM1 genotypes, and colorectal adenomas
73. Glutathione S-transferase mu1 and N-acetyltransferase 2 polymorphisms and exposure to tobacco smoke in nonsmoking and smoking lung cancer patients and population controls
74. NAT2 slow acetylator genotype is associated with increased risk of lung cancer among non-smoking Chinese women in Singapore
75. Inherited GSTM1 and NAT2 defects as concurrent risk modifiers for asbestos associated human malignant mesothelioma
76. Human lung carcinogen-DNA adduct levels mediated by genetic polymorhisms in vivo
77. Glutathione S-transferase M1 status and lung cancer risk: A meta-analysis
78. Effect of vitamin intervention on the relationship between GSTM1, smoking, and lung cancer risk among male smokers
79. Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans
80. Polymorphisms in the glutathione S-transferase class mu and theta genes interact and increase susceptibility to lung cancer in minority populations (Texas, United States)
81. Environmental tobacco smoke, genetic susceptibility, and risk of lung cancer in never-smoking women
82. Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers
83. Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P450 gene
84. Polymorphisms of the CYP1A1 and glutathione S-transferase genes associated with susceptibility to lung cancer in relation to cigarette dose in a Japanese population
85. Association between a cytochrome P450 CYP1A1 genotype and incidence of lung cancer
86. The relationship between CYP1A1 aryl hydroxylase activity and lung cancer in a Japanese population
87. High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes
88. Susceptibility to lung cancer in light smokers associated with CYP1A1 polymorphisms in Mexican and African Americans
89. Age at menarche, urine estrogens, and breast cancer risk
90. Towards an understanding of breast cancer aetiology
91. A prospective study of endogenous estrogens and breast cancer in postmenopausal women
92. Plasma sex steroid hormones and risk of breast cancer in postmenopausal women
93. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: A potential biomarker of breast cancer risk
94. The role of aromatic hydrocarbons in the genesis of breast cancer
95. Dietary carcinogens and mammary carcinogenesis. Induction of rat mammary carcinomas by administration of heterocyclic amines in cooked foods
96. A CYP1A1 RFLP is associated with breast cancer in African-American women
97. Role of estradiol metabolism in CYP1A1 polymorphisms in breast cancer risk
98. Genetics of CYP1A1: Coamplification of specific alleles by polymerase chain reaction and association with breast cancer
99. Cigarette smoking, cytochrome P450 1A1 polymorphisms, and breast cancer risk in the Nurses' Health Study
100. Cytochrome P4501A1 and glutathione S-transferase (M1) genetic polymorphisms and postmenopausal breast cancer risk
101. Cytochrome P450 1A1 polymorphism as a susceptibility factor for breast cancer in postmenopausal women in Taiwan
102. Genetic polymorphisms of cytochrome P450-1B1 and risk of breast cancer
103. Association of cytochrome P450 1B1 (CYP1B1) polymorphism with receptor status in breast cancer
104. Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer
105. No association between a polymorphism in the steroid metabolism gene CYP17 and risk of breast cancer
106. Association between CYP17 polymorphisms and the development of breast cancer
107. CYP17 genotype and breast cancer risk
108. Association between CYP17 gene polymorphism and risk of breast cancer in young women
109. A rare CYP19 (aromatase) variant may increase the risk of breast cancer
110. Constitutional genetic variation at the human aromatase gene (Cyp19) and breast cancer risk
111. Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility
112. Association between glutathione S-transferase M1, P1, and T1 genetic polymorphisms and development of breast cancer
113. Glutathione S-transferase mu and theta polymorphisms and breast susceptibility
114. Alcohol consumption, glutathione S-transferase M1 and T1 genetic polymorphisms and breast cancer risk
115. Polymorphisms of glutathione S-transferase genes (GSTM1, GSTP1 and GSTT1) and breast cancer susceptibility
116. The association between glutathione S-transferase M1 genotype and polycyclic aromatic hydrocarbon-DNA adducts in breast tissue
117. Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients
118. The association of polymorphic N-acetyltransferase (NAT2) in relation to breast cancer risk
119. Cigarette smoking, N-acetyltransferase 2 genetic polymorphisms, and breast cancer risk
120. N-Acetyltransferase-2 genetic polymorphism, well-done meat intake, and breast cancer risk among postmenopausal women
121. Breast cancer and active and passive smoking: The role of the N-acetyltransferase 2 genotype
122. N-acetyl transferase 2 genotypes, meat intake and breast cancer risk
123. A prospective study of NAT2 acetylation genotype, cigarette smoking, and risk of breast cancer
124. Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk
125. A C4887A polymorphism in exon 7 of human CYP1A1. Population frequency, mutation linkages, and impact on lung cancer susceptibility
126. Slow acetylator mutations in the human polymorphic N-acetyltransferase gene in 786 Asians, Blacks Hispanics and Whites: Application to metabolic epidemiology
127. Ethnic distribution of slow acetylator mutations in the polymorphic N-acetyletrasferase (NAT2) gene
128. Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations
129. Distribution of composite CYP1A1 genotypes in Africans, African Americans, and Caucasians
130. Glutathione S-transferase polymorphisms and colorectal cancer: A HuGE review
131. Lung cancer risk, occupational exposure, and the debrisoquine metabolic phenotype